• Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70.


    Google Scholar     

  • Castle EM, Greenwood SA, Müller RU. The importance of lifestyle interventions in the prevention and treatment of chronic kidney disease. Kidney Dial. 2023;3(2):192–5.


    Google Scholar     

  • Wang L, Xu X, Zhang M, Hu C, Zhang X, Li C, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298–310.


    Google Scholar     

  • Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436–46.


    Google Scholar     

  • Zoccali C, Mark PB, Sarafidis P, Agarwal R, Adamczak M, de Bueno R, et al. Diagnosis of cardiovascular disease in patients with chronic kidney disease. Nat Rev Nephrol. 2023;19(11):733–46.


    Google Scholar     

  • Shajahan S, Amin J, Phillips JK, Hildreth CM. Relationship between sex and cardiovascular mortality in chronic kidney disease: A systematic review and meta-analysis. PLoS ONE. 2021;16(7):e0254554.


    Google Scholar     

  • Swartling O, Rydell H, Stendahl M, Segelmark M, Trolle Lagerros Y, Evans M. CKD progression and mortality among men and women: A nationwide study in Sweden. Am J Kidney Dis. 2021;78(2):190–e1991.


    Google Scholar     

  • Wang V, Vilme H, Maciejewski ML, Boulware LE. The economic burden of chronic kidney disease and End-Stage renal disease. Semin Nephrol. 2016;36(4):319–30.


    Google Scholar     

  • Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47–64.


    Google Scholar     

  • Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and Pharmacological implications. Gut. 2020;69(9):1691–705.


    Google Scholar     

  • Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore. Nat Rev Gastroenterol Hepatol. 2022r;19(3):153–68.


    Google Scholar     

  • Caldart F, de Pretis N, Luchini C, Ciccocioppo R, Frulloni L. Pancreatic steatosis and metabolic pancreatic disease: a new entity? Intern Emerg Med. 2023;18(8):2199–208.


    Google Scholar     

  • Olivero A, Basso L, Barabino E, Milintenda P, Testino N, Chierigo F, et al. The impact of visceral adipose tissue on postoperative renal function after radical nephrectomy for renal cell carcinoma. Minerva Urol Nephrol. 2021;73(6):789–95.


    Google Scholar     

  • Bilson J, Mantovani A, Byrne CD, Targher G. Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metab. 2024;50(1):101506.


    Google Scholar     

  • Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, et al. MAFLD and risk of CKD. Metabolism. 2021;115:154433.


    Google Scholar     

  • Wang TY, Wang RF, Bu ZY, Targher G, Byrne CD, Sun DQ, et al. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol. 2022;18(4):259–68.


    Google Scholar     

  • Wang Z, do Carmo JM, da Silva AA, Fu Y, Hall JE. Mechanisms of synergistic interactions of diabetes and hypertension in chronic kidney disease: role of mitochondrial dysfunction and ER stress. Curr Hypertens Rep. 2020;22(2):15.


    Google Scholar     

  • Olesen SS, Poulsen JL, Novovic S, Nøjgaard C, Kalaitzakis E, Jensen NM, et al. Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases. United Eur Gastroenterol J. 2020;8(4):453–61.


    Google Scholar     

  • Zhang Y, Liu Y, Petrov MS. Relationship of fat in the pancreas with cardiovascular disease: A systematic review and meta-analysis. Obes Rev. 2025;26(7):e13914.


    Google Scholar     

  • Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

  • Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New Creatinine- and Cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–49.


    Google Scholar     

  • Ramkissoon R, Gardner TB. Pancreatic steatosis: an emerging clinical entity. Am J Gastroenterol. 2019;114(11):1726–34.


    Google Scholar     

  • Wagner R, Eckstein SS, Yamazaki H, Gerst F, Machann J, Jaghutriz BA, et al. Metabolic implications of pancreatic fat accumulation. Nat Rev Endocrinol. 2022;18(1):43–54.


    Google Scholar     

  • Yamazaki H, Streicher SA, Wu L, Fukuhara S, Wagner R, Heni M, et al. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. Cell Rep Med. 2024;5:101391.


    Google Scholar     

  • Gao J, Li Y, Zhang Y, Zhan X, Tian X, Li J, et al. Severity and remission of metabolic Dysfunction–Associated Fatty/Steatotic liver disease with chronic kidney disease occurrence. J Am Heart Assoc. 2024;13(5):e032604.


    Google Scholar     

  • Wei S, Song J, Xie Y, Huang J, Yang J. Metabolic dysfunction-associated fatty liver disease can significantly increase the risk of chronic kidney disease in adults with type 2 diabetes. Diabetes Res Clin Pract. 2023;197:110563.


    Google Scholar     

  • Yang M, Geng CA, Liu X, Guan M. Lipid disorders in NAFLD and chronic kidney disease. Biomedicines. 2021;9(10):1405.


    Google Scholar     

  • Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease. Clin J Am Soc Nephrol CJASN. 2017;12(12):2032–45.


    Google Scholar     

  • Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905–6.


    Google Scholar     

  • Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, et al. Inflammation-Related mechanisms in chronic kidney disease Prediction, Progression, and outcome. J Immunol Res. 2018;2018:2180373.


    Google Scholar     

  • Tsai YW, Chan YL, Chen YC, Cheng YH, Chang SS. Association of elevated blood serum high-sensitivity C-reactive protein levels and body composition with chronic kidney disease: A population-based study in Taiwan. Med (Baltim). 2018;97(36):e11896.


    Google Scholar     

  • Singh RG, Nguyen NN, Cervantes A, Alarcon Ramos GC, Cho J, Petrov MS. Associations between intra-pancreatic fat deposition and Circulating levels of cytokines. Cytokine. 2019;120:107–14.


    Google Scholar     

  • Trudeau KM, Colby AH, Zeng J, Las G, Feng JH, Grinstaff MW, et al. Lysosome acidification by photoactivated nanoparticles restores autophagy under lipotoxicity. J Cell Biol. 2016;214(1):25–34.


    Google Scholar     

  • Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med Berl Ger. 2010;88(10):993–1001.


    Google Scholar